Regimens for inoperable locally advanced non-small cell lung cancer
10.3760/cma.j.issn.1673-422X.2014.04.013
- VernacularTitle:无法手术局部晚期非小细胞肺癌的治疗
- Author:
Jiang XI
;
Wenhui LI
;
Li WANG
- Publication Type:Journal Article
- Keywords:
Carcinoma,non-small-cell lung;
Radiotherapy;
Drug therapy
- From:
Journal of International Oncology
2014;41(4):279-282
- CountryChina
- Language:Chinese
-
Abstract:
Concurrent chemoradiotherapy is the optimal regimen for patients with inoperable locally advanced non-small cell lung cancer (LA-NSCLC).The application of new technologies such as positron emission tomography (PET)/CT and four dimensional CT (4D-CT) enhances the accuracy of radiotherapy and decreases adverse reaction.Induction chemotherapy and consolidation chemotherapy do not show benefit to survival.The targeted therapy and immunotherapy have the potential of improving the outcomes of inoperable LA-NSCLC.
